Negative surveillance endoscopy occurs frequently in patients with short-segment non-dysplastic Barrett's esophagus

被引:6
作者
Melson, J. [1 ]
Desai, V. [1 ]
Greenspan, M. [1 ]
Yau, S. [1 ]
Abdalla, M. [1 ]
Dhanekula, R. [1 ]
Mobarhan, S. [1 ]
Shapiro, D. [1 ]
Losurdo, J. [1 ]
Jakate, S. [1 ]
机构
[1] Rush Univ, Dept Med, Div Digest Dis, Med Ctr, Chicago, IL 60612 USA
关键词
Barrett's esophagus; esophagogastroduodenoscopy; screening; COLUMNAR LINED ESOPHAGUS; LARGE MULTICENTER COHORT; PREMALIGNANT CONDITIONS; INTESTINAL METAPLASIA; FOLLOW-UP; DIAGNOSIS; ADENOCARCINOMA; PREVALENCE; HISTOLOGY; CANCER;
D O I
10.1111/dote.12250
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Surveillance endoscopy of non-dysplastic Barrett's esophagus (NDBE) that fails to detect intestinal metaplasia (IM), or negative surveillance, is known to occur in clinical practice, although the frequency and possible outcomes in a large cohort in clinical practice is not well described. The goals of this study were to define frequency in which negative surveillance occurs and endoscopic outcomes in a screening cohort of short segment NDBE. A retrospective cohort (n = 184) of patients newly diagnosed with short segment NDBE at an outpatient academic tertiary care center between 2003 and 2011 were reviewed. Only those with one or more surveillance endoscopies were included to define a frequency of negative surveillance. Included patients were further assessed if they had two or more surveillance endoscopies and were classified into groups as sampling error or negative IM on consecutive surveillances based on the results of their surveillance endoscopies. The frequency of a negative surveillance endoscopy in all short-segment NDBE patients was 19.66% (92 endoscopic exams were negative for IM of 468 total surveillance exams). A negative surveillance endoscopy occurred in 40.76% (n = 75) patients. Sampling error occurred in 44.12% and negative IM on consecutive surveillance endoscopies in 55.88% of those with 2 surveillance endoscopies and an initially negative surveillance exam. The frequency of negative IM on consecutive surveillances was 19.00% of all patients who had two surveillance endoscopies. When the index diagnostic Barrett's esophagus segment length was <1cm, 32.14% (18/56) of all patients (with 2 surveillance endoscopies) had negative IM on consecutive surveillance endoscopies. Negative surveillance occurs frequently in short-segment NDBE. When an initial negative surveillance endoscopy occurs, it may be due to either a sampling error or lack of detectable IM on surveillance exam. When a <1cm segment of NDBE is diagnosed, a significant proportion of patients may go on to have continuously undetected IM on consecutive surveillance endoscopic exams without intervention.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 50 条
[21]   Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients [J].
Yagi, K ;
Nakamura, A ;
Sekine, A .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (06) :929-934
[22]   Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus [J].
Pinto, Rita ;
Hauge, Tobias ;
Jeanmougin, Marine ;
Pharo, Heidi D. ;
Kresse, Stine H. ;
Honne, Hilde ;
Winge, Sara B. ;
Five, May-Britt ;
Kumar, Theresa ;
Mala, Tom ;
Hauge, Truls ;
Johnson, Egil ;
Lind, Guro E. .
CLINICAL EPIGENETICS, 2022, 14 (01)
[23]   Late Results of the Surgical Treatment of 125 Patients With Short-Segment Barrett Esophagus [J].
Csendes, Attila ;
Braghetto, Italo ;
Burdiles, Patricio ;
Smok, Gladys ;
Henriquez, Ana ;
Maria Burgos, Ana .
ARCHIVES OF SURGERY, 2009, 144 (10) :921-927
[24]   Expanding beyond endoscopy: A review of non-invasive modalities in Barrett's esophagus screening and surveillance [J].
Shahsavari, Dariush ;
Kudaravalli, Praneeth ;
Yap, John Erikson L. ;
Vega, Kenneth J. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (32) :4516-4526
[25]   Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett's esophagus: a systematic review and meta-analysis [J].
Chandrasekar, Viveksandeep Thoguluva ;
Hamade, Nour ;
Desai, Madhav ;
Rai, Tarun ;
Gorrepati, Venkata Subhash ;
Jegadeesan, Ramprasad ;
Sathyamurthy, Anjana ;
Sharma, Prateek .
ENDOSCOPY, 2019, 51 (07) :665-672
[26]   The effect of reactive atypia/inflammation on the laser-induced fluorescence diagnosis of non-dysplastic Barrett's esophagus [J].
Panjehpour, Masoud ;
Overholt, Bergein F. ;
Tuan Vo-Dinh ;
Coppola, Domenico .
LASERS IN SURGERY AND MEDICINE, 2012, 44 (05) :390-396
[27]   Somatic DNA copy number alterations in non-dysplastic Barrett’s esophagus [J].
Zachary M. Callahan ;
Wennuan Liu ;
Jun Hou ;
S. Lilly Zheng ;
Jamaal Rehman ;
H. Mason Hedberg ;
Craig S. Brown ;
Bailey Su ;
Mikhail Attaar ;
Kristine Kuchta ;
MaryAnn Regner ;
JoAnn Carbray ;
Jianfeng Xu ;
Michael Ujiki .
Surgical Endoscopy, 2021, 35 :3961-3970
[28]   Deep Learning for Whole-Slide Tissue Histopathology Classification: A Comparative Study in the Identification of Dysplastic and Non-Dysplastic Barrett's Esophagus [J].
Sali, Rasoul ;
Moradinasab, Nazanin ;
Guleria, Shan ;
Ehsan, Lubaina ;
Fernandes, Philip ;
Shah, Tilak U. ;
Syed, Sana ;
Brown, Donald E. .
JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04) :1-16
[29]   Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagus [J].
Rita Pinto ;
Tobias Hauge ;
Marine Jeanmougin ;
Heidi D. Pharo ;
Stine H. Kresse ;
Hilde Honne ;
Sara B. Winge ;
May-Britt Five ;
Theresa Kumar ;
Tom Mala ;
Truls Hauge ;
Egil Johnson ;
Guro E. Lind .
Clinical Epigenetics, 2022, 14
[30]   Adenocarcinoma developing in short-segment Barrett's esophagus: analysis of 5 patients and review of the literature [J].
Csendes, A. ;
Braghetto, I. ;
Burdiles, P. ;
Smok, G. .
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2007, 39 (06) :359-363